Larimar Therapeutics, Inc.

Historical 13F Holders

Symbol
LRMR
CUSIP
98885E103
All holders as of
Q1 2020
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2020 Q1 44 26.3 M $20.2 M
2019 Q4 52 25.2 M $28.0 M
2019 Q3 52 23.0 M $17.0 M
2019 Q2 72 26.4 M $31.5 M
2019 Q1 88 28.6 M $78.5 M
2018 Q4 96 31.4 M $155 M
2018 Q3 94 26.3 M $307 M
2018 Q2 91 25.5 M $261 M
2018 Q1 66 15.3 M $114 M
2017 Q4 56 13.6 M $62.9 M
2017 Q3 63 13.4 M $47.0 M
2017 Q2 70 13.3 M $46.8 M
2017 Q1 83 14.2 M $66.3 M
2016 Q4 86 13.8 M $43.8 M
2016 Q3 82 13.9 M $45.9 M
2016 Q2 78 17.2 M $103 M
2016 Q1 86 19.0 M $127 M
2015 Q4 97 20.0 M $126 M
2015 Q3 103 21.8 M $708 M
2015 Q2 92 21.3 M $737 M
2015 Q1 96 24.3 M $880 M
2014 Q4 59 15.7 M $485 M
2014 Q3 44 14.7 M $289 M
2014 Q2 5 1.45 M $28.6 M